Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.58% |
| 2 | Energy | 8.65% |
| 3 | Industrials | 8.54% |
| 4 | Technology | 7.61% |
| 5 | Communication Services | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Synchrony
SYF
$26.1B
| $52.5M | 0.02% |
1,359,511
-294,308
| -18% | -$10.1M |
|
577
Expedia Group
EXPE
$39.4B
| $52.4M | 0.02% |
437,566
+83,647
| +24% | +$10.9M |
|
578
Blackstone Mortgage Trust
BXMT
$2.44B
| $52.3M | 0.02% |
1,626,405
-94,368
| -5% | -$3.03M |
|
579
Healthcare Services Group
HCSG
$1.45B
| $52.2M | 0.02% |
990,935
+4,849
| +0.5% | +$254K |
|
580
State Street SPDR S&P Metals & Mining ETF
XME
$4.46B
| $52.2M | 0.02% |
1,435,978
+1,400,545
| +3,953% | +$45.7M |
|
581
Alamos Gold
AGI
$13.8B
| $52.2M | 0.02% |
8,020,373
+5,083,002
| +173% | +$33.2M |
|
582
Progressive
PGR
$121B
| $52.2M | 0.02% |
926,989
-282,881
| -23% | -$14.6M |
|
583
Schwab US Broad Market ETF
SCHB
$45.2B
| $52.1M | 0.02% |
4,847,184
+348,948
| +8% | +$3.66M |
|
584
Landstar System
LSTR
$6.4B
| $52M | 0.02% |
499,600
-6,000
| -1% | -$603K |
|
585
Eastman Chemical
EMN
$8.43B
| $52M | 0.02% |
560,966
+262,515
| +88% | +$23.9M |
|
586
National Grid
NGG
$81.6B
| $51.9M | 0.02% |
997,261
-116,584
| -10% | -$6.22M |
|
587
NetEase
NTES
$78.5B
| $51.8M | 0.02% |
751,085
-22,240
| -3% | -$1.39M |
|
|
HES
588
PUT
DELISTED
Hess
HES
| $51.8M | 0.02% |
1,090,900
+173,600
| +19% | +$7.83M |
|
589
Jacobs Solutions
J
$16.8B
| $51.4M | 0.02% |
941,647
+36,975
| +4% | +$1.9M |
|
|
RP
590
DELISTED
RealPage, Inc.
RP
| $51.3M | 0.02% |
1,158,414
-47,711
| -4% | -$2.08M |
|
591
MACOM Technology Solutions
MTSI
$23.5B
| $51.2M | 0.02% |
1,573,723
+166,554
| +12% | +$6.02M |
|
592
TriMas Corp
TRS
$1.39B
| $51.1M | 0.02% |
1,908,854
+195,361
| +11% | +$5.2M |
|
593
PUT
Gilead Sciences
GILD
$171B
| $50.9M | 0.02% |
709,800
+411,300
| +138% | +$31.2M |
|
594
CALL
Adobe
ADBE
$108B
| $50.7M | 0.02% |
289,600
-41,200
| -12% | -$7.09M |
|
|
CMD
595
DELISTED
Cantel Medical Corporation
CMD
| $50.7M | 0.02% |
493,116
-33,294
| -6% | -$3.32M |
|
596
iShares TIPS Bond ETF
TIP
$14.7B
| $50.6M | 0.02% |
443,339
+23,135
| +6% | +$2.63M |
|
597
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.67B
| $50.3M | 0.02% |
854,500
+373,800
| +78% | +$21.5M |
|
598
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| $50.2M | 0.02% |
918,085
+84,147
| +10% | +$4.53M |
|
599
Vertex Pharmaceuticals
VRTX
$131B
| $50.2M | 0.02% |
335,168
+171,670
| +105% | +$25.4M |
|
600
Analog Devices
ADI
$186B
| $50M | 0.02% |
561,528
-40,177
| -7% | -$3.56M |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.